Inbrain Neuroelectronics secures funding for AI-powered graphene-brain interface
Inbrain Neuroelectronics has announced that it has raised US)$18.8 million in series A funding for its artificial intelligence […]
Inbrain Neuroelectronics has announced that it has raised US)$18.8 million in series A funding for its artificial intelligence […]
Rapid Medical has announced the US Food and Drug Administration (FDA) clearance of its Tigertriever revascularisation device […]
Helius Medical Technologies has announced that its Portable Neuromodulation Stimulator (PoNS) device, for multiple sclerosis sufferers, […]
The FDA has authorized a new device to help adults with mild to moderate […]
Refractory focal epilepsy treatment developer NeuroPace last week filed with the SEC to raise up […]
NeuroPace is hoping to raise $75 million in an initial public offering. The Mountain View, […]
Dive Brief: FDA has authorized Helius Medical Technologies’ neuromodulation stimulator to improve the gait of multiple […]
Medtronic has announced that the US Food and Drug Administration (FDA) has approved the revised […]
GyroGear, a UK-based neuromuscular medical device company, has landed $4.3 million in phase one of […]
Neuropace, maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, filed SEC documents […]
Viz.ai, a startup developing clinical decision support tools for stroke detection, raised $71 million in […]
MagVenture has introduced the MagVenture Flow Arm — a patent-pending, clinical positioning system to optimise […]
BrainQ, an Israeli start-up with an artificial intelligence- (AI) powered therapeutic platform, has announced the […]
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced […]
The digitization of implanted devices continues apace. On Monday, Abbott announced the launch of its […]
Second Sight Medical (NSDQ: EYES) today announced that the FDA has approved its Argus 2s retinal […]
Neurolief today announced that it received FDA approval for its Relivion noninvasive neuromodulation system to […]
The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for […]
Evasc Neurovascular has announced its successful application to France’s Ministry of Health (Haute Autorité de […]
Results from a phase II clinical trial conducted by vascular neurologists at Cedar-Sinai, Los Angeles, […]
Ching-Jen Chen discusses his recent publication in the BMJ entitled, “Is a picture-perfect thrombectomy necessary […]
New research on therapeutic virtual reality reports that an in-home, interactive program for chronic pain […]
Newronika has announced the CE mark approval for its AlphaDBS system to treat Parkinson’s disease. According to a company press […]
Medtronic has received approval from the US Food and Drug Administration (FDA) for expanded magnetic […]
Neurostimulation technology developer Mainstay Medical announced that it closed an equity financing worth gross proceeds […]
Theranica announced today that it has signed a contract to supply its Nerivio device […]
Cerus Endovascular today said it has received FDA breakthrough device designation for its Contour Neurovascular System. […]
CereVasc has announced the treatment of the first patient in a study of its eShunt […]
Maria Bennett, co-founder and CEO of Cleveland-based SPR Therapeutics, has been studying pain relief using […]
Vesalio has announced in a company press release that it has received 510(k) clearance from […]
Biomodex has announced its partnership with two of the top medical centres in France and […]
Cirtec Medical is making proprietary information about a neuromodulation device — purchased from bankrupt […]
Medtronic today announced an early site limited release of its recently acquired Rist radial access […]
Longeviti Neuro Solutions has announced the 510(k) clearance by the US Food and Drug Administration […]
Boston Scientific has landed FDA clearance for its Vercise Genus Deep Brain Stimulation (DBS) System. This […]
Boston Scientific won a nod from FDA for its fourth-generation Vercise Genus Deep Brain Stimulation […]
Abbott has announced the launch of its NeuroSphere myPath digital health app, designed to track […]
New single-centre clinical study data published in the Journal of Neuroradiology claims to support the […]
Medtronic has announced the first enrollment in its trial evaluating the safety and efficacy of […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.